Business
Benson Hill Unveils Ambitious Expansion into Animal Feed Markets, Stock Surges
In a strategic move aimed at bolstering its financial standing and pivoting towards an asset-light business model, Benson Hill, a pioneering food tech company specializing...
8×8, Inc – Q2 Fiscal 2024 Financial Results Reveals Strong Performance, Stock Surges
8×8, Inc, a prominent provider of integrated cloud contact center and unified communications solutions, unveiled its financial results for the second quarter (Q2) of fiscal...
DarioHealth Corp Reports Q3 2023 Results: Revenue Decline Sparks Market Response
DarioHealth Corp, a prominent player in the global digital health market, released its financial results for the third quarter (Q3) of 2023 today, revealing a...
Starbucks Brews Up Impressive Fiscal Q4 Earnings, but International Markets Tell a Different Story
Starbucks Corporation reported its fiscal fourth-quarter (Q4) earnings early Thursday morning, unveiling a mixed bag of results that showcased the diverging trends in the United...
Bank of England Maintains UK Interest Rates at 15-Year High
The Bank of England has opted to maintain its benchmark interest rate at 5.25%, holding steady as inflation levels continue to recede from their previous...
Gannett Co Reports Q3 2023 Financial Results, Stock Declines
Gannett Co, a mass media holding company, released its financial results for the third quarter (Q3) ending September 30, 2023, today, revealing a 9.1% decrease...
POET Technologies Stock Declines Following Public Offerings in US and Canada
Stock of POET Technologies (NASDAQ: POET) experienced a significant drop of over 26%, plummeting to $2.00 on Thursday. This decline comes in the wake of...
Acurx Pharmaceuticals Stock Faces Volatility After CDI Trial Results Release
Acurx Pharmaceuticals, a clinical-stage biopharmaceutical company at the forefront of developing a groundbreaking class of small molecule antibiotics targeting resilient bacterial infections, unveiled promising efficacy...
Outlook Therapeutics Stock Plummets Following FDA Requirements
In a major blow to Outlook Therapeutics, stock of the biopharmaceutical company plummeted by more than 50% in premarket trading on Thursday. The sharp decline...
Nikola Announces Q3 2023 Results Amid Recall, Stock Surges
Nikola Corporation, a prominent player in the global zero-emissions transportation and energy sector, unveiled its financial results for the third quarter (Q3) of 2023. Despite...